Global Implantable Drug Eluting Devices Market Research Report 2025(Status and Outlook)

October 2025 | 154 pages | ID: G99EA26938DFEN
Bosson Research

Abstracts

Report Overview

Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.

The global Implantable Drug Eluting Devices market size was estimated at USD 12530.42 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Implantable Drug Eluting Devices market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Implantable Drug Eluting Devices market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Implantable Drug Eluting Devices market

Global Implantable Drug Eluting Devices Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Pfizer
Medtronic
Merck
Bayer AG
Johnson & Johnson
Abbott
Surmodics
Boston Scientific Corporation
Titan PharmaceuticalsInc.
BIOTRONIK
Allergan
Bausch & Lomb
REVA Medical
MicroPort Medical

Market Segmentation (by Type)

Implantable Drug Infusion Pumps
Intraocular Drug-Eluting Devices
Contraceptive Drug-Eluting Devices
Drug-Eluting Stents
Others

Market Segmentation (by Application)

Diabetes
Contraception
HIV/AIDS Prevention
Chronic Pain Management
Cardiovascular
Ophthalmology
Oncology
Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Implantable Drug Eluting Devices Market
• Overview of the regional outlook of the Implantable Drug Eluting Devices Market.

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Implantable Drug Eluting Devices Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Implantable Drug Eluting Devices, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Implantable Drug Eluting Devices
1.2 Key Market Segments
  1.2.1 Implantable Drug Eluting Devices Segment by Type
  1.2.2 Implantable Drug Eluting Devices Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 IMPLANTABLE DRUG ELUTING DEVICES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Implantable Drug Eluting Devices Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Implantable Drug Eluting Devices Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 IMPLANTABLE DRUG ELUTING DEVICES MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Implantable Drug Eluting Devices Product Life Cycle
3.3 Global Implantable Drug Eluting Devices Sales by Manufacturers (2020-2025)
3.4 Global Implantable Drug Eluting Devices Revenue Market Share by Manufacturers (2020-2025)
3.5 Implantable Drug Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Implantable Drug Eluting Devices Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Implantable Drug Eluting Devices Market Competitive Situation and Trends
  3.8.1 Implantable Drug Eluting Devices Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Implantable Drug Eluting Devices Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 IMPLANTABLE DRUG ELUTING DEVICES INDUSTRY CHAIN ANALYSIS

4.1 Implantable Drug Eluting Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF IMPLANTABLE DRUG ELUTING DEVICES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Implantable Drug Eluting Devices Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Implantable Drug Eluting Devices Market
5.7 ESG Ratings of Leading Companies

6 IMPLANTABLE DRUG ELUTING DEVICES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Implantable Drug Eluting Devices Sales Market Share by Type (2020-2025)
6.3 Global Implantable Drug Eluting Devices Market Size Market Share by Type (2020-2025)
6.4 Global Implantable Drug Eluting Devices Price by Type (2020-2025)

7 IMPLANTABLE DRUG ELUTING DEVICES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Implantable Drug Eluting Devices Market Sales by Application (2020-2025)
7.3 Global Implantable Drug Eluting Devices Market Size (M USD) by Application (2020-2025)
7.4 Global Implantable Drug Eluting Devices Sales Growth Rate by Application (2020-2025)

8 IMPLANTABLE DRUG ELUTING DEVICES MARKET SALES BY REGION

8.1 Global Implantable Drug Eluting Devices Sales by Region
  8.1.1 Global Implantable Drug Eluting Devices Sales by Region
  8.1.2 Global Implantable Drug Eluting Devices Sales Market Share by Region
8.2 Global Implantable Drug Eluting Devices Market Size by Region
  8.2.1 Global Implantable Drug Eluting Devices Market Size by Region
  8.2.2 Global Implantable Drug Eluting Devices Market Size Market Share by Region
8.3 North America
  8.3.1 North America Implantable Drug Eluting Devices Sales by Country
  8.3.2 North America Implantable Drug Eluting Devices Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Implantable Drug Eluting Devices Sales by Country
  8.4.2 Europe Implantable Drug Eluting Devices Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Implantable Drug Eluting Devices Sales by Region
  8.5.2 Asia Pacific Implantable Drug Eluting Devices Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Implantable Drug Eluting Devices Sales by Country
  8.6.2 South America Implantable Drug Eluting Devices Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Implantable Drug Eluting Devices Sales by Region
  8.7.2 Middle East and Africa Implantable Drug Eluting Devices Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 IMPLANTABLE DRUG ELUTING DEVICES MARKET PRODUCTION BY REGION

9.1 Global Production of Implantable Drug Eluting Devices by Region(2020-2025)
9.2 Global Implantable Drug Eluting Devices Revenue Market Share by Region (2020-2025)
9.3 Global Implantable Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Implantable Drug Eluting Devices Production
  9.4.1 North America Implantable Drug Eluting Devices Production Growth Rate (2020-2025)
  9.4.2 North America Implantable Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Implantable Drug Eluting Devices Production
  9.5.1 Europe Implantable Drug Eluting Devices Production Growth Rate (2020-2025)
  9.5.2 Europe Implantable Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Implantable Drug Eluting Devices Production (2020-2025)
  9.6.1 Japan Implantable Drug Eluting Devices Production Growth Rate (2020-2025)
  9.6.2 Japan Implantable Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Implantable Drug Eluting Devices Production (2020-2025)
  9.7.1 China Implantable Drug Eluting Devices Production Growth Rate (2020-2025)
  9.7.2 China Implantable Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Pfizer
  10.1.1 Pfizer Basic Information
  10.1.2 Pfizer Implantable Drug Eluting Devices Product Overview
  10.1.3 Pfizer Implantable Drug Eluting Devices Product Market Performance
  10.1.4 Pfizer Business Overview
  10.1.5 Pfizer SWOT Analysis
  10.1.6 Pfizer Recent Developments
10.2 Medtronic
  10.2.1 Medtronic Basic Information
  10.2.2 Medtronic Implantable Drug Eluting Devices Product Overview
  10.2.3 Medtronic Implantable Drug Eluting Devices Product Market Performance
  10.2.4 Medtronic Business Overview
  10.2.5 Medtronic SWOT Analysis
  10.2.6 Medtronic Recent Developments
10.3 Merck
  10.3.1 Merck Basic Information
  10.3.2 Merck Implantable Drug Eluting Devices Product Overview
  10.3.3 Merck Implantable Drug Eluting Devices Product Market Performance
  10.3.4 Merck Business Overview
  10.3.5 Merck SWOT Analysis
  10.3.6 Merck Recent Developments
10.4 Bayer AG
  10.4.1 Bayer AG Basic Information
  10.4.2 Bayer AG Implantable Drug Eluting Devices Product Overview
  10.4.3 Bayer AG Implantable Drug Eluting Devices Product Market Performance
  10.4.4 Bayer AG Business Overview
  10.4.5 Bayer AG Recent Developments
10.5 Johnson and Johnson
  10.5.1 Johnson and Johnson Basic Information
  10.5.2 Johnson and Johnson Implantable Drug Eluting Devices Product Overview
  10.5.3 Johnson and Johnson Implantable Drug Eluting Devices Product Market Performance
  10.5.4 Johnson and Johnson Business Overview
  10.5.5 Johnson and Johnson Recent Developments
10.6 Abbott
  10.6.1 Abbott Basic Information
  10.6.2 Abbott Implantable Drug Eluting Devices Product Overview
  10.6.3 Abbott Implantable Drug Eluting Devices Product Market Performance
  10.6.4 Abbott Business Overview
  10.6.5 Abbott Recent Developments
10.7 Surmodics
  10.7.1 Surmodics Basic Information
  10.7.2 Surmodics Implantable Drug Eluting Devices Product Overview
  10.7.3 Surmodics Implantable Drug Eluting Devices Product Market Performance
  10.7.4 Surmodics Business Overview
  10.7.5 Surmodics Recent Developments
10.8 Boston Scientific Corporation
  10.8.1 Boston Scientific Corporation Basic Information
  10.8.2 Boston Scientific Corporation Implantable Drug Eluting Devices Product Overview
  10.8.3 Boston Scientific Corporation Implantable Drug Eluting Devices Product Market Performance
  10.8.4 Boston Scientific Corporation Business Overview
  10.8.5 Boston Scientific Corporation Recent Developments
10.9 Titan PharmaceuticalsInc.
  10.9.1 Titan PharmaceuticalsInc. Basic Information
  10.9.2 Titan PharmaceuticalsInc. Implantable Drug Eluting Devices Product Overview
  10.9.3 Titan PharmaceuticalsInc. Implantable Drug Eluting Devices Product Market Performance
  10.9.4 Titan PharmaceuticalsInc. Business Overview
  10.9.5 Titan PharmaceuticalsInc. Recent Developments
10.10 BIOTRONIK
  10.10.1 BIOTRONIK Basic Information
  10.10.2 BIOTRONIK Implantable Drug Eluting Devices Product Overview
  10.10.3 BIOTRONIK Implantable Drug Eluting Devices Product Market Performance
  10.10.4 BIOTRONIK Business Overview
  10.10.5 BIOTRONIK Recent Developments
10.11 Allergan
  10.11.1 Allergan Basic Information
  10.11.2 Allergan Implantable Drug Eluting Devices Product Overview
  10.11.3 Allergan Implantable Drug Eluting Devices Product Market Performance
  10.11.4 Allergan Business Overview
  10.11.5 Allergan Recent Developments
10.12 Bausch and Lomb
  10.12.1 Bausch and Lomb Basic Information
  10.12.2 Bausch and Lomb Implantable Drug Eluting Devices Product Overview
  10.12.3 Bausch and Lomb Implantable Drug Eluting Devices Product Market Performance
  10.12.4 Bausch and Lomb Business Overview
  10.12.5 Bausch and Lomb Recent Developments
10.13 REVA Medical
  10.13.1 REVA Medical Basic Information
  10.13.2 REVA Medical Implantable Drug Eluting Devices Product Overview
  10.13.3 REVA Medical Implantable Drug Eluting Devices Product Market Performance
  10.13.4 REVA Medical Business Overview
  10.13.5 REVA Medical Recent Developments
10.14 MicroPort Medical
  10.14.1 MicroPort Medical Basic Information
  10.14.2 MicroPort Medical Implantable Drug Eluting Devices Product Overview
  10.14.3 MicroPort Medical Implantable Drug Eluting Devices Product Market Performance
  10.14.4 MicroPort Medical Business Overview
  10.14.5 MicroPort Medical Recent Developments

11 IMPLANTABLE DRUG ELUTING DEVICES MARKET FORECAST BY REGION

11.1 Global Implantable Drug Eluting Devices Market Size Forecast
11.2 Global Implantable Drug Eluting Devices Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Implantable Drug Eluting Devices Market Size Forecast by Country
  11.2.3 Asia Pacific Implantable Drug Eluting Devices Market Size Forecast by Region
  11.2.4 South America Implantable Drug Eluting Devices Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Implantable Drug Eluting Devices by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Implantable Drug Eluting Devices Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Implantable Drug Eluting Devices by Type (2026-2033)
  12.1.2 Global Implantable Drug Eluting Devices Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Implantable Drug Eluting Devices by Type (2026-2033)
12.2 Global Implantable Drug Eluting Devices Market Forecast by Application (2026-2033)
  12.2.1 Global Implantable Drug Eluting Devices Sales (K Units) Forecast by Application
  12.2.2 Global Implantable Drug Eluting Devices Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Implantable Drug Eluting Devices Market Size Comparison by Region (M USD)
Table 5. Global Implantable Drug Eluting Devices Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Implantable Drug Eluting Devices Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Implantable Drug Eluting Devices Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Implantable Drug Eluting Devices Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Drug Eluting Devices as of 2024)
Table 10. Global Market Implantable Drug Eluting Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Implantable Drug Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Implantable Drug Eluting Devices Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Implantable Drug Eluting Devices Sales by Type (K Units)
Table 26. Global Implantable Drug Eluting Devices Market Size by Type (M USD)
Table 27. Global Implantable Drug Eluting Devices Sales (K Units) by Type (2020-2025)
Table 28. Global Implantable Drug Eluting Devices Sales Market Share by Type (2020-2025)
Table 29. Global Implantable Drug Eluting Devices Market Size (M USD) by Type (2020-2025)
Table 30. Global Implantable Drug Eluting Devices Market Size Share by Type (2020-2025)
Table 31. Global Implantable Drug Eluting Devices Price (USD/Unit) by Type (2020-2025)
Table 32. Global Implantable Drug Eluting Devices Sales (K Units) by Application
Table 33. Global Implantable Drug Eluting Devices Market Size by Application
Table 34. Global Implantable Drug Eluting Devices Sales by Application (2020-2025) & (K Units)
Table 35. Global Implantable Drug Eluting Devices Sales Market Share by Application (2020-2025)
Table 36. Global Implantable Drug Eluting Devices Market Size by Application (2020-2025) & (M USD)
Table 37. Global Implantable Drug Eluting Devices Market Share by Application (2020-2025)
Table 38. Global Implantable Drug Eluting Devices Sales Growth Rate by Application (2020-2025)
Table 39. Global Implantable Drug Eluting Devices Sales by Region (2020-2025) & (K Units)
Table 40. Global Implantable Drug Eluting Devices Sales Market Share by Region (2020-2025)
Table 41. Global Implantable Drug Eluting Devices Market Size by Region (2020-2025) & (M USD)
Table 42. Global Implantable Drug Eluting Devices Market Size Market Share by Region (2020-2025)
Table 43. North America Implantable Drug Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 44. North America Implantable Drug Eluting Devices Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Implantable Drug Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 46. Europe Implantable Drug Eluting Devices Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Implantable Drug Eluting Devices Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Implantable Drug Eluting Devices Market Size by Region (2020-2025) & (M USD)
Table 49. South America Implantable Drug Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 50. South America Implantable Drug Eluting Devices Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Implantable Drug Eluting Devices Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Implantable Drug Eluting Devices Market Size by Region (2020-2025) & (M USD)
Table 53. Global Implantable Drug Eluting Devices Production (K Units) by Region(2020-2025)
Table 54. Global Implantable Drug Eluting Devices Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Implantable Drug Eluting Devices Revenue Market Share by Region (2020-2025)
Table 56. Global Implantable Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Implantable Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Implantable Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Implantable Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Implantable Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Pfizer Basic Information
Table 62. Pfizer Implantable Drug Eluting Devices Product Overview
Table 63. Pfizer Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Pfizer Business Overview
Table 65. Pfizer SWOT Analysis
Table 66. Pfizer Recent Developments
Table 67. Medtronic Basic Information
Table 68. Medtronic Implantable Drug Eluting Devices Product Overview
Table 69. Medtronic Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Medtronic Business Overview
Table 71. Medtronic SWOT Analysis
Table 72. Medtronic Recent Developments
Table 73. Merck Basic Information
Table 74. Merck Implantable Drug Eluting Devices Product Overview
Table 75. Merck Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Merck Business Overview
Table 77. Merck SWOT Analysis
Table 78. Merck Recent Developments
Table 79. Bayer AG Basic Information
Table 80. Bayer AG Implantable Drug Eluting Devices Product Overview
Table 81. Bayer AG Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Recent Developments
Table 84. Johnson and Johnson Basic Information
Table 85. Johnson and Johnson Implantable Drug Eluting Devices Product Overview
Table 86. Johnson and Johnson Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Johnson and Johnson Business Overview
Table 88. Johnson and Johnson Recent Developments
Table 89. Abbott Basic Information
Table 90. Abbott Implantable Drug Eluting Devices Product Overview
Table 91. Abbott Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Abbott Business Overview
Table 93. Abbott Recent Developments
Table 94. Surmodics Basic Information
Table 95. Surmodics Implantable Drug Eluting Devices Product Overview
Table 96. Surmodics Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Surmodics Business Overview
Table 98. Surmodics Recent Developments
Table 99. Boston Scientific Corporation Basic Information
Table 100. Boston Scientific Corporation Implantable Drug Eluting Devices Product Overview
Table 101. Boston Scientific Corporation Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Boston Scientific Corporation Business Overview
Table 103. Boston Scientific Corporation Recent Developments
Table 104. Titan PharmaceuticalsInc. Basic Information
Table 105. Titan PharmaceuticalsInc. Implantable Drug Eluting Devices Product Overview
Table 106. Titan PharmaceuticalsInc. Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Titan PharmaceuticalsInc. Business Overview
Table 108. Titan PharmaceuticalsInc. Recent Developments
Table 109. BIOTRONIK Basic Information
Table 110. BIOTRONIK Implantable Drug Eluting Devices Product Overview
Table 111. BIOTRONIK Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. BIOTRONIK Business Overview
Table 113. BIOTRONIK Recent Developments
Table 114. Allergan Basic Information
Table 115. Allergan Implantable Drug Eluting Devices Product Overview
Table 116. Allergan Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Allergan Business Overview
Table 118. Allergan Recent Developments
Table 119. Bausch and Lomb Basic Information
Table 120. Bausch and Lomb Implantable Drug Eluting Devices Product Overview
Table 121. Bausch and Lomb Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Bausch and Lomb Business Overview
Table 123. Bausch and Lomb Recent Developments
Table 124. REVA Medical Basic Information
Table 125. REVA Medical Implantable Drug Eluting Devices Product Overview
Table 126. REVA Medical Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. REVA Medical Business Overview
Table 128. REVA Medical Recent Developments
Table 129. MicroPort Medical Basic Information
Table 130. MicroPort Medical Implantable Drug Eluting Devices Product Overview
Table 131. MicroPort Medical Implantable Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. MicroPort Medical Business Overview
Table 133. MicroPort Medical Recent Developments
Table 134. Global Implantable Drug Eluting Devices Sales Forecast by Region (2026-2033) & (K Units)
Table 135. Global Implantable Drug Eluting Devices Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Implantable Drug Eluting Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 137. North America Implantable Drug Eluting Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Implantable Drug Eluting Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 139. Europe Implantable Drug Eluting Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Implantable Drug Eluting Devices Sales Forecast by Region (2026-2033) & (K Units)
Table 141. Asia Pacific Implantable Drug Eluting Devices Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Implantable Drug Eluting Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 143. South America Implantable Drug Eluting Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Implantable Drug Eluting Devices Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Implantable Drug Eluting Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Implantable Drug Eluting Devices Sales Forecast by Type (2026-2033) & (K Units)
Table 147. Global Implantable Drug Eluting Devices Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Implantable Drug Eluting Devices Price Forecast by Type (2026-2033) & (USD/Unit)
Table 149. Global Implantable Drug Eluting Devices Sales (K Units) Forecast by Application (2026-2033)
Table 150. Global Implantable Drug Eluting Devices Market Size Forecast by Application (2026-2033) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Implantable Drug Eluting Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Implantable Drug Eluting Devices Market Size (M USD), 2024-2033
Figure 5. Global Implantable Drug Eluting Devices Market Size (M USD) (2020-2033)
Figure 6. Global Implantable Drug Eluting Devices Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Implantable Drug Eluting Devices Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Implantable Drug Eluting Devices Product Life Cycle
Figure 13. Implantable Drug Eluting Devices Sales Share by Manufacturers in 2024
Figure 14. Global Implantable Drug Eluting Devices Revenue Share by Manufacturers in 2024
Figure 15. Implantable Drug Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Implantable Drug Eluting Devices Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Implantable Drug Eluting Devices Revenue in 2024
Figure 18. Industry Chain Map of Implantable Drug Eluting Devices
Figure 19. Global Implantable Drug Eluting Devices Market PEST Analysis
Figure 20. Global Implantable Drug Eluting Devices Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Implantable Drug Eluting Devices Market Share by Type
Figure 27. Sales Market Share of Implantable Drug Eluting Devices by Type (2020-2025)
Figure 28. Sales Market Share of Implantable Drug Eluting Devices by Type in 2024
Figure 29. Market Size Share of Implantable Drug Eluting Devices by Type (2020-2025)
Figure 30. Market Size Share of Implantable Drug Eluting Devices by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Implantable Drug Eluting Devices Market Share by Application
Figure 33. Global Implantable Drug Eluting Devices Sales Market Share by Application (2020-2025)
Figure 34. Global Implantable Drug Eluting Devices Sales Market Share by Application in 2024
Figure 35. Global Implantable Drug Eluting Devices Market Share by Application (2020-2025)
Figure 36. Global Implantable Drug Eluting Devices Market Share by Application in 2024
Figure 37. Global Implantable Drug Eluting Devices Sales Growth Rate by Application (2020-2025)
Figure 38. Global Implantable Drug Eluting Devices Sales Market Share by Region (2020-2025)
Figure 39. Global Implantable Drug Eluting Devices Market Size Market Share by Region (2020-2025)
Figure 40. North America Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Implantable Drug Eluting Devices Sales Market Share by Country in 2024
Figure 43. North America Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Implantable Drug Eluting Devices Market Size Market Share by Country in 2024
Figure 45. U.S. Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Implantable Drug Eluting Devices Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Implantable Drug Eluting Devices Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Implantable Drug Eluting Devices Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Implantable Drug Eluting Devices Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Implantable Drug Eluting Devices Sales Market Share by Country in 2024
Figure 53. Europe Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Implantable Drug Eluting Devices Market Size Market Share by Country in 2024
Figure 55. Germany Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Implantable Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Implantable Drug Eluting Devices Sales Market Share by Region in 2024
Figure 67. Asia Pacific Implantable Drug Eluting Devices Market Size Market Share by Region in 2024
Figure 68. China Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Implantable Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 79. South America Implantable Drug Eluting Devices Sales Market Share by Country in 2024
Figure 80. South America Implantable Drug Eluting Devices Market Size and Growth Rate (M USD)
Figure 81. South America Implantable Drug Eluting Devices Market Size Market Share by Country in 2024
Figure 82. Brazil Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Implantable Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Implantable Drug Eluting Devices Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Implantable Drug Eluting Devices Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Implantable Drug Eluting Devices Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Implantable Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Implantable Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Implantable Drug Eluting Devices Production Market Share by Region (2020-2025)
Figure 103. North America Implantable Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Implantable Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Implantable Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 106. China Implantable Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Implantable Drug Eluting Devices Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Implantable Drug Eluting Devices Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Implantable Drug Eluting Devices Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Implantable Drug Eluting Devices Market Share Forecast by Type (2026-2033)
Figure 111. Global Implantable Drug Eluting Devices Sales Forecast by Application (2026-2033)
Figure 112. Global Implantable Drug Eluting Devices Market Share Forecast by Application (2026-2033)